Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replication

[1] Finzi D(1999)Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy Nat Med 5 512-517

[2] Blankson J(2011)Curing HIV: Pharmacologic approaches to target HIV-1 latency Annu Rev Pharmacol Toxicol 51 397-418

[3] Siliciano JD(2009)Interim data released from inspire study on interleukin-7 AIDS Patient Care STDs 23 987-988

[4] Margolick JB(2005)Depletion of latent HIV-1 infection in vivo: a proof-of-concept study Lancet 366 549-555

[5] Chadwick K(2008)Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir AIDS 22 1125-1129

[6] Pierson T(2009)IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection Blood 113 6304-6314

[7] Smith K(2007)Stability of the latent reservoir for HIV-1 in patients receiving valproic acid J Infect Dis 195 833-836

[8] Lisziewicz J(2002)Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial) AIDS 16 1479-1487

[9] Lori F(2004)The multifactorial nature of HIV-1 latency Trends Mol Med 10 525-531

[10] Flexner C(1994)Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2 J Virol 68 1993-1997

[1] Finzi D(1999)Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy Nat Med 5 512-517

[2] Blankson J(2011)Curing HIV: Pharmacologic approaches to target HIV-1 latency Annu Rev Pharmacol Toxicol 51 397-418

[3] Siliciano JD(2009)Interim data released from inspire study on interleukin-7 AIDS Patient Care STDs 23 987-988

[4] Margolick JB(2005)Depletion of latent HIV-1 infection in vivo: a proof-of-concept study Lancet 366 549-555

[5] Chadwick K(2008)Prolonged valproic acid treatment does not reduce the size of latent HIV reservoir AIDS 22 1125-1129

[6] Pierson T(2009)IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection Blood 113 6304-6314

[7] Smith K(2007)Stability of the latent reservoir for HIV-1 in patients receiving valproic acid J Infect Dis 195 833-836

[8] Lisziewicz J(2002)Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial) AIDS 16 1479-1487

[9] Lori F(2004)The multifactorial nature of HIV-1 latency Trends Mol Med 10 525-531

[10] Flexner C(1994)Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2 J Virol 68 1993-1997